ArticlePLoS neglected tropical diseases2026
Occurrence of Angiostrongylus cantonensis in invasive snails in the French territories of America, French Guiana, Guadeloupe, and Martinique.
Article in PLoS neglected tropical diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAngiostrongylus cantonensis is the primary etiological agent of eosinophilic meningitis, transmitted through rats (definitive hosts) and molluscs (potential intermediate hosts). Human infection occurs accidentally through the ingestion of contaminated hosts. First reported in the French West Indies in 2002, cases of A. cantonensis infections are emerging due to the spread of its hosts, particularly the invasive African giant snail (Lissachatina fulica). This study aims to assess the prevalence of A. cantonensis in gastropods across Guadeloupe, Martinique, and French Guiana, providing insights into its transmission dynamics. METHODOLOGY/PRINCIPAL
findingsTerrestrial gastropods were collected in 2017 from residential areas with prior human cases and other selected sites with no reported case. The gastropods' species were identified by a malacologist and processed for DNA extraction. Molecular diagnosis of A. cantonensis was performed using quantitative PCR. Prevalence rates were analyzed by Chi-square and Kruskal-Wallis tests, while correlations between weight and level of A. cantonensis DNA detected were assessed via Spearman's rank correlation. A total of 430 gastropods, representing nine species, were collected: 103 from Guadeloupe, 161 from Martinique, and 166 from French Guiana. The highest prevalence of A. cantonensis was observed in Guadeloupe (38.8%), followed by Martinique (27.6%) and French Guiana (15.7%). Sampling in Martinique included a wider diversity of gastropod species, whereas collections in French Guiana and Guadeloupe were limited to Lissachatina spp. In Martinique, eight species were identified, five of which were infected. The prevalence was positively correlated with weight in the primary intermediate host, L. fulica. Interestingly, Lissachatina immaculata in French Guiana was confirmed as a potential intermediate host for the first time. CONCLUSIONS/SIGNIFICANCE: The study highlights L. fulica as the predominant host in Guadeloupe and Martinique, while L. immaculata plays a significant role in French Guiana. Gastropod diversity and prevalence varied across territories, influenced by collection methods and ecological factors. Despite high infection rates in gastropods, human cases remain relatively rare, likely due to limited human-gastropod interaction and local culinary practices. These findings underscore the need for further investigation into transmission dynamics and phylogenetic studies to inform public health strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.